Generate a structured brief — facts, issues, held, reasoning, and significance — for this case in seconds. Or browse the verbatim judgment via the source links below.
(a)���� a person diagnosed positive for Hepatitis C (HCV) resulting from the use of Human Immunoglobulin Anti-D within the State,
(b)���� a person diagnosed positive for HCV through the transfusion of blood or blood products within the State,
(c)���� the children or any spouse, of the persons at (a) or (b) above who themselves have been diagnosed positive for HCV.
3.������ The deceased contracted HCV on the 11th June 1977 as a result of receiving Anti-D which emanated from a batch of the product contaminated with the virus (subsequently identified as batch number 238). A stark difference of medical opinion emerged in the course of the proceedings concerning the part played, if any, by HCV in the cause of the deceased�s death. In the event the Tribunal was not satisfied that HCV had played an active role in the death (to a degree that could be said to be non-minimal), and consequently dismissed the application.
6.������ The parties made comprehensive written and oral submissions on the issues which arose before the Tribunal, as they did on the appeal. In the interests of facilitating a comprehensive understanding and in order to place the issues in context it is considered necessary to set out in some detail the factual background to the application.�
Auto-extracted from BAILII. Full structured brief in progress — the source links below give you the verbatim judgment in the meantime.
Multiple official and mirror sources — pick whichever loads cleanly on your network.
Common Room
0 comments · About the Common Room →
No comments yet — start the discussion.
Voted-best comments help future students and feed Caselaw's AI study tools.